AllianceBernstein
SRRA

AllianceBernstein’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

AllianceBernstein’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-504,530
Closed -$27.7M – 3350
2022
Q2 		$27.7M Buy
+504,530
New +$26.5M 0.01% 759

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

AllianceBernstein's SRRA Position: Q3 2022 in Review

AllianceBernstein sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 504,530 shares — an estimated $27.7M sold.

AllianceBernstein first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $27.7M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • AllianceBernstein reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AllianceBernstein sold 504,530 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $27.7M.
  • AllianceBernstein first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • AllianceBernstein's Sierra Oncology, Inc. Common Stock position peaked at $27.7M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.